Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ·Healthcare·Biotechnology
$5.71
-0.52%
Mkt Cap $163.43M
Analyst Ratings
Buy
3
Hold
1
Sell
0
Price Target (14 analysts)
$22.50
Range $20.00 – $25.00
Implied Upside
+294.0%
Consensus $22.50 vs current $5.71